Second Drug for Benign Synovial Tumor Condition Wins FDA Approval

(MEDPAGE today)-The Food and Drug Administration (FDA) agreed to the small molecules VimSeltinib (romvimza) for adults who suffer from a giant cell tumor of symptoms of Tenosynovial (TGCT), which is a rare, not mixed, but emerging condition in the ziph . ..